Literature DB >> 19136476

15-Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS.

Do-Hee Kim1, Jung-Hyun Kim, Eun-Hee Kim, Hye-Kyung Na, Young-Nam Cha, Jin Ho Chung, Young-Joon Surh.   

Abstract

Heme oxygenase-1 (HO-1) has recently been found to be involved in angiogenesis and metastasis. In this study, we investigated whether HO-1 could potentiate the metastatic potential of human breast cancer cells. Treatment of MCF-7 and MDA-MB-231 cells with 30 microM of 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) increased the expression of HO-1, which preceded the induction of matrix metalloproteinases (MMPs). The 15d-PGJ2-induced upregulation of MMP-1 was abrogated by the HO-1 inhibitor zinc protoporphyrin IX (ZnPP) as well as introduction of HO-1 short interfering RNA. In addition, HO-1 inducers, such as cobalt protoporphyrin IX and hemin, upregulated the expression of MMP-1. Overexpression of HO-1 in the MCF-7 cells caused the induction of MMP-1 expression. Treatment with the HO-1 inhibitor ZnPP abolished the migrative phenotype of 15d-PGJ2-treated MCF-7 cells. MCF-7 cells treated with 15d-PGJ2 exhibited intracellular accumulation of reactive oxygen species (ROS) which was abolished by ZnPP. We hypothesize that excess iron, released as a consequence HO-1 activity induced by 15d-PGJ2, is transiently available for the stimulation of intracellular ROS generation and subsequently MMP-1 expression. 15d-PGJ2-mediated upregulation of MMP-1 expression was blocked by the iron chelator desferrioxamine and the Fe2+-specific chelator 1,10-phenanthroline. The iron chelators as well as the antioxidant N-acetyl-L-cysteine abrogated ROS formation by 15d-PGJ2. In conclusion, 15d-PGJ2 upregulates MMP-1 expression via induction of HO-1 and subsequent production of iron capable of generating ROS, which may contribute to increased metastasis and invasiveness of the human breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19136476     DOI: 10.1093/carcin/bgp012

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  18 in total

Review 1.  Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis.

Authors:  Joydeb Kumar Kundu; Young-Joon Surh
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

2.  Haem oxygenase 1 expression is associated with prognosis in cholangiocarcinoma patients and with drug sensitivity in xenografted mice.

Authors:  S Kongpetch; A Puapairoj; C K Ong; L Senggunprai; A Prawan; U Kukongviriyapan; W Chan-On; E Y Siew; N Khuntikeo; B T Teh; V Kukongviriyapan
Journal:  Cell Prolif       Date:  2016-01-04       Impact factor: 6.831

3.  Lipocalin-2 enhances angiogenesis in rat brain endothelial cells via reactive oxygen species and iron-dependent mechanisms.

Authors:  Limin Wu; Yang Du; Josephine Lok; Eng H Lo; Changhong Xing
Journal:  J Neurochem       Date:  2015-01-29       Impact factor: 5.372

4.  A new target for squamous cell skin cancer?

Authors:  Dongwon Kim; Luis A Garza
Journal:  Exp Dermatol       Date:  2015-01       Impact factor: 3.960

Review 5.  Iron imbalance in cancer: Intersection of deficiency and overload.

Authors:  Tulika Basak; Rupinder Kaur Kanwar
Journal:  Cancer Med       Date:  2022-04-22       Impact factor: 4.711

6.  Do iron chelators increase the antiproliferative effect of trichostatin A through a glucose-regulated protein 78 mediated mechanism?

Authors:  Veli Kilinc; Abdulkerim Bedir; Ali Okuyucu; Osman Salis; Hasan Alacam; Sedat Gulten
Journal:  Tumour Biol       Date:  2014-03-13

7.  The role of peroxisome proliferator-activated receptors in colorectal cancer.

Authors:  Joo-In Park; Jong-Young Kwak
Journal:  PPAR Res       Date:  2012-09-11       Impact factor: 4.964

8.  The role of cyclooxygenase-2, interleukin-1β and fibroblast growth factor-2 in the activation of matrix metalloproteinase-1 in sheared-chondrocytes and articular cartilage.

Authors:  Pei-Pei Guan; Jing-Wen Guo; Xin Yu; Yue Wang; Tao Wang; Konstantinos Konstantopoulos; Zhan-You Wang; Pu Wang
Journal:  Sci Rep       Date:  2015-05-20       Impact factor: 4.379

9.  15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.

Authors:  Ki Rim Kim; Hyun Jeong Kim; Sun Kyoung Lee; Gwang Taek Ma; Kwang Kyun Park; Won Yoon Chung
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

10.  4-Hydroxyestradiol induces mammary epithelial cell transformation through Nrf2-mediated heme oxygenase-1 overexpression.

Authors:  Sin-Aye Park; Mee-Hyun Lee; Hye-Kyung Na; Young-Joon Surh
Journal:  Oncotarget       Date:  2017-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.